1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (right to buy)
|
01/16/2010(1)
|
01/15/2017 |
Common Stock $0.01 par value per share
|
30,000
|
$
1.23
|
D
|
Â
|
Stock Option (right to buy)
|
05/10/2010(1)
|
05/09/2017 |
Common Stock $0.01 par value per share
|
15,000
|
$
1.65
|
D
|
Â
|
Stock Option (right to buy)
|
05/14/2011(1)
|
05/13/2018 |
Common Stock $0.01 par value per share
|
45,000
|
$
0.85
|
D
|
Â
|
Stock Option (right to buy)
|
11/12/2011(1)
|
11/11/2018 |
Common Stock $0.01 par value per share
|
20,000
|
$
0.47
|
D
|
Â
|
Stock Option (right to buy)
|
11/11/2012(1)
|
11/11/2019 |
Common Stock $0.01 par value per share
|
45,000
|
$
1.1
|
D
|
Â
|
Stock Option (right to buy)
|
11/11/2013(1)
|
11/10/2020 |
Common Stock $0.01 par value per share
|
35,000
|
$
1.52
|
D
|
Â
|
Stock Option (right to buy)
|
05/17/2015(1)
|
05/16/2022 |
Common Stock $0.01 par value per share
|
20,000
|
$
2.94
|
D
|
Â
|
Stock Option (right to buy)
|
05/22/2016(1)
|
05/22/2023 |
Common Stock $0.01 par value per share
|
30,000
|
$
3.96
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(2)
|
11/19/2024 |
Common Stock $0.01 par value per share
|
35,000
|
$
2.29
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(3)
|
05/29/2024 |
Common Stock $0.01 par value per share
|
35,000
|
$
3.09
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(4)
|
05/28/2025 |
Common Stock $0.01 par value per share
|
35,000
|
$
2.18
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(5)
|
06/02/2026 |
Common Stock $0.01 par value per share
|
40,000
|
$
1.12
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vested in equal quarterly installments over three years from the initial grant date. The exercisable date listed above represents the date the options became fully vested and exercisable. |
(2) |
Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on November 20, 2014 and are vesting in equal quarterly installments over three years from the initial grant date. |
(3) |
Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on May 29, 2014 and are vesting in equal quarterly installments over three years from the initial grant date. |
(4) |
Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on May 28, 2015 and are vesting in equal quarterly installments over three years from the initial grant date. |
(5) |
Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on June 2, 2016 and are vesting in equal quarterly installments over three years from the initial grant date. |